Provided by Tiger Fintech (Singapore) Pte. Ltd.

Argenx SE

599.87
+4.170.70%
Post-market: 599.870.00000.00%19:56 EDT
Volume:332.85K
Turnover:199.51M
Market Cap:36.63B
PE:46.94
High:602.10
Open:598.33
Low:594.24
Close:595.70
Loading ...

Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients

Benzinga
·
09 Apr

William Blair healthcare analysts hold an analyst/industry conference call

TIPRANKS
·
09 Apr

Is Argenx SE (ARGX) The Most Profitable Biotech Stock To Buy Right Now?

Insider Monkey
·
02 Apr

JAZZ or ARGX: Which Is the Better Value Stock Right Now?

Zacks
·
31 Mar

Argenx SE Files 2024 Annual Report Highlighting VYVGART Expansion

TIPRANKS
·
21 Mar

Evercore ISI Reaffirms Their Buy Rating on Argenx Se (ARGX)

TIPRANKS
·
18 Mar

AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study

Zacks
·
18 Mar

European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading

MT Newswires Live
·
13 Mar

argenx : UBS Raises Target Price to $620 From $600

THOMSON REUTERS
·
12 Mar

Artisan Small Cap Fund Sold argenx SE (ARGX) as it Exceeded Small-Cap Mandate

Insider Monkey
·
11 Mar

argenx Is Maintained at Buy by Guggenheim

Dow Jones
·
10 Mar

argenx Se : Guggenheim Raises Target Price to $1,100 From $775

THOMSON REUTERS
·
10 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week

MT Newswires Live
·
08 Mar

Argenx announces Vyvgart, Vyvgart Hytrulo data

TIPRANKS
·
07 Mar

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity

Blockhead
·
05 Mar

argenx Is Maintained at Neutral by Baird

Dow Jones
·
04 Mar

Argenx Se (ARGX) Receives a Buy from Morgan Stanley

TIPRANKS
·
03 Mar

Truist Financial Sticks to Their Buy Rating for Argenx Se (ARGX)

TIPRANKS
·
03 Mar

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus

Zacks
·
01 Mar

Argenx's Q4 Sales Backed by Vyvgart's Growth, Oppenheimer Says

MT Newswires Live
·
01 Mar